In 2021 and 2022 over 500 people benefited from our online and interactive IO educational forums and now for 2024 it is time to join us in Manchester. Come together with immuno-oncology professionals from across the country at this face-to-face training conference. Learn from experts in their field, in a friendly and informative environment and leave this event with increased knowledge of cardiovascular, immune, fatigue, neurological, respiratory and musculoskeletal toxicities.
Immuno-oncology providers are welcome to attend as conference sponsors. Please contact Sarah Kemm for further details.
Other events of interest:

5 hours Continuing Professional Development: what you will learn
Join us in Manchester to benefit from an excellent opportunity to refresh your knowledge with a good balance between scientific, practical and multi-professional learning. This dedicated forum will focus on:
Invitation to sponsor
9:00 |
Registration and networking
|
9:30 |
Chair’s opening remarks and introductions
Lisa Barrott, Macmillan Nurse and AHP Lead for Cancer, Specialist Palliative Care and End of Life Care, University Hospitals Sussex NHS Foundation Trust
|
Managing side effects | |
9:40 |
Management of immunotherapy-induced cardiotoxicity
Dr Rebecca Dobson, Consultant Cardiologist, Liverpool Heart and Chest Hospital NHS Foundation Trust
|
10:05 |
Identifying and treating immune hepatitis and nephritis IO related side effects
Dr Jo Ocen, Consultant Medical Oncologist, Velindre Cancer Centre, Velindre University NHS Trust
|
10:30 |
Questions and answers with your speakers
|
10:40 |
Sponsored presentation opportunity
|
11:00 |
Screen break and opportunity to meet the sponsors
|
Treating adverse effects | |
11:20 |
Assessing and treating fatigue resulting from immuno-oncology
Helen Grist, Immunotherapy CNS, Worcestershire Acute Hospitals NHS Trust
|
11:45 |
Interactive discussion: Benchmark your experience of assessing and managing toxicities
|
12:05 |
Feedback from interactive discussion on Benchmark your experience of assessing and managing toxicities
|
12:15 |
Sponsored presentation opportunity
|
12:35 |
Networking lunch and opportunity to meet the sponsors
|
Identifying toxicities | |
1:30 |
Recognising and treating neurological toxicities secondary to IO
Dr Aisling Carr, Consultant Neurologist, UCL Queen Square Institute of Neurology, University College London
|
1:55 |
Questions and answers with your speakers
|
2:05 |
Interactive discussion: Supporting and educating A&E and community teams to escalate immunotherapy patients appropriately
|
2:25 |
Feedback from interactive discussion: Supporting and educating A&E and community teams to escalate immunotherapy patients appropriately
|
2:35 |
Networking break and final opportunity meet the sponsors
|
2:50 |
Assessing and managing respiratory side effects of immuno-oncology
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
3:15 |
Assessing, triaging and treating immune-related musculoskeletal toxicities
|
3:40 |
Questions and answers with your speaker
|
3:50 |
Close of day
|
Your confirmed speakers to date:
Lisa has had a varied nursing career, working in burns and then general intensive care before moving into oncology approximately 15 years ago. Since moving to cancer care she has worked in a variety of areas, including research, ambulatory care, Acute Oncology and Cancer of Unknown Primary; and has also undertaken different roles including clinical nurse specialist, nurse manager, Cancer Matron and Chemotherapy Nurse Consultant.
Lisa recently moved to University Hospitals Sussex NHS Foundation Trust as the Macmillan Nurse and AHP Lead for Cancer, Palliative and EOLC. She works closely with Cancer Alliances, Commissioning Groups and National charities to develop services locally and nationally.
Lisa is very interested in the development of extended practice roles and innovative, new models of care that allow patients to have their treatments closer to home, outside the hospital setting. She is a strong advocate of nurse education and supporting specialist cancer nurses to meet the challenges they face professionally. She is keen to ensure oncology nurses have a strong voice in shaping policies and services across the four nations through involvement with key organisations and industry. Lisa is currently undertaking a part-time PhD through King’s College London looking at multi-professional SACT clinics.
Expected attendees
Previously held as an online meeting, this face-to-face conference is ideal for NHS professionals working in immunotherapy MDTs. This includes but is not limited to:
Past attendee feedback
“This has been a really useful update on toxicities of immunotherapy”
West Hertfordshire Teaching Hospitals NHS Trust, Identifying and Treating Immuno-Oncology (IO) Adverse Effects, December 2022
“The presentations are so helpful and will help manage patients in clinical practice”
Surrey and Sussex NHS Healthcare Trust, Identifying and Treating Immuno-Oncology (IO) Adverse Effects, December 2022
“An excellent morning. Really enjoyed the balance between the (complex) science of checkpoint inhibitors and case studies that illustrated the importance of careful assessment and multi-professional working relationships”
Somerset NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021
“Excellent, relevant, worthwhile and informative. The best online forum I have attended”
University Hospitals Trust Sussex NHS Foundation Trust, Recognising and Treating IO Side Effects, November 2021
“Great session with experts who were knowledgeable and explained things very well”
Worcester Acute NHS Trust, Recognising and Treating IO Side Effects, November 2021
“Excellent. One of the best I've attended. Pitched perfectly and I understood it!”
West Hertfordshire Hospitals NHS Trust, Recognising and Treating IO Side Effects, July 2021
“I found it very friendly, and very informative. It was nice to talk to other areas before the presentations started in small groups and learn a bit about how other areas process are for triage and assessment of their patients”
Sheffield Teaching Hospitals NHS Foundation Trust, Recognising and Treating IO Side Effects, July 2021
“I am so grateful for the knowledge acquired through my first virtual conference. It was very well organised with technical support provided, very efficient. Speakers were excellent and content very appropriate and relevant”
Royal Surrey NHS Foundation Trust, Managing Side Effects of Cancer Immunotherapy, December 2020
“Informative, friendly and highly appropriate content. Really exciting day as it felt like networking and being present at a physical conference, so thank you for making it so warm and welcoming”
Western Sussex Hospitals NHS Trust, Managing Side Effects of Cancer Immunotherapy, December 2020